MBXBF (Microbix Biosystems) Total Stockholders Equity : $21.64 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Microbix Biosystems Total Stockholders Equity?

Microbix Biosystems's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $21.64 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Microbix Biosystems's Book Value per Share for the quarter that ended in Mar. 2025 was $0.15. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Microbix Biosystems's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.17.

Microbix Biosystems Total Stockholders Equity Historical Data

The historical data trend for Microbix Biosystems's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Total Stockholders Equity Chart

Microbix Biosystems Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Total Stockholders Equity

Get a 7-Day Free Trial

5.00

14.64

18.70

18.20

20.89

Microbix Biosystems Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															20.51	20.45	20.89	20.29	21.64

Microbix Biosystems (OTCPK:MBXBF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Microbix Biosystems's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(21.639	-	0)	/	141.636
	=	0.15

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Microbix Biosystems's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.068	+	3.659)	/	21.639
	=	0.17

Microbix Biosystems Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Microbix Biosystems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (OTCPK:MBXBF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

MBX:Canada

Address

265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3

Website

https://www.microbix.com

Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and; Development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.